In the present study we evaluated immune-inflammatory and metabolic effects of a treatment with high dose furosemide + HSS by means of analysis of changes of cytokine, natriuretic peptide, visfatin and leptin serum levels in subjects with cirrhosis and refractory ascites. The gene discussed is LEP; the disease is Cirrhosis.